FDA Warning Letter — Manhattan Regenerative Medicine Medical Group
The FDA took a Warning Letter action against Manhattan Regenerative Medicine Medical Group on December 30, 2015 (New York, NY). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Manhattan Regenerative Medicine Medical Group
- Date
- December 30, 2015
- Fiscal Year
- 2016
- Product Type
- Biologics
- Center
- CBER
- Location
- New York, NY (United States)